These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16432664)

  • 21. Racial differences in breast cancer survival in the Detroit Metropolitan area.
    Simon MS; Banerjee M; Crossley-May H; Vigneau FD; Noone AM; Schwartz K
    Breast Cancer Res Treat; 2006 May; 97(2):149-55. PubMed ID: 16322888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone receptors in breast cancer: racial differences in distribution and survival.
    Joslyn SA
    Breast Cancer Res Treat; 2002 May; 73(1):45-59. PubMed ID: 12083631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast.
    Xu R; Feiner H; Li P; Yee H; Inghirami G; Delgado Y; Perle MA
    Arch Pathol Lab Med; 2003 Nov; 127(11):1458-64. PubMed ID: 14567723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.
    Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
    Ann Surg Oncol; 2007 Oct; 14(10):2994-3003. PubMed ID: 17647064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
    Elledge RM; Clark GM; Chamness GC; Osborne CK
    J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of triple-negative tumors in an urban cancer center.
    Lund MJ; Butler EN; Bumpers HL; Okoli J; Rizzo M; Hatchett N; Green VL; Brawley OW; Oprea-Ilies GM; Gabram SG
    Cancer; 2008 Aug; 113(3):608-15. PubMed ID: 18484596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYC amplification in subtypes of breast cancers in African American women.
    Naab TJ; Gautam A; Ricks-Santi L; Esnakula AK; Kanaan YM; DeWitty RL; Asgedom G; Makambi KH; Abawi M; Blancato JK
    BMC Cancer; 2018 Mar; 18(1):274. PubMed ID: 29523126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.
    Tan F; Mosunjac M; Adams AL; Adade B; Taye O; Hu Y; Rizzo M; Ofori-Acquah SF
    BMC Cancer; 2014 Sep; 14():715. PubMed ID: 25255861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
    Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS
    Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interactions between GPR30 and the major biomarkers in infiltrating ductal carcinoma of the breast in an Asian population.
    Kuo WH; Chang LY; Liu DL; Hwa HL; Lin JJ; Lee PH; Chen CN; Lien HC; Yuan RH; Shun CT; Chang KJ; Hsieh FJ
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):135-45. PubMed ID: 17638621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of age, tumor size, lymph node metastasis, stage, receptor status and menopausal status on overall survival of breast cancer patients in Pakistan.
    Mahmood H; Faheem M; Mahmood S; Sadiq M; Irfan J
    Asian Pac J Cancer Prev; 2015; 16(3):1019-24. PubMed ID: 25735323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Her-2/neu status: a neglected marker of prognostication and management of breast cancer patients in India.
    Zubeda S; Kaipa PR; Shaik NA; Mohiuddin MK; Vaidya S; Pavani B; Srinivasulu M; Latha MM; Hasan Q
    Asian Pac J Cancer Prev; 2013; 14(4):2231-5. PubMed ID: 23725118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophages as independent prognostic factors in small T1 breast cancers.
    Carrio R; Koru-Sengul T; Miao F; Glück S; Lopez O; Selman Y; Alvarez C; Milikowski C; Gomez C; Jorda M; Nadji M; Torroella-Kouri M
    Oncol Rep; 2013 Jan; 29(1):141-8. PubMed ID: 23076599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer.
    Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Vergote I; Christiaens MR
    Ann Oncol; 2005 Nov; 16(11):1755-61. PubMed ID: 16085689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.
    Jiagge E; Jibril AS; Chitale D; Bensenhaver JM; Awuah B; Hoenerhoff M; Adjei E; Bekele M; Abebe E; Nathanson SD; Gyan K; Salem B; Oppong J; Aitpillah F; Kyei I; Bonsu EO; Proctor E; Merajver SD; Wicha M; Stark A; Newman LA
    Ann Surg Oncol; 2016 Nov; 23(12):3843-3849. PubMed ID: 27469125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do we need HER-2/neu testing for all patients with primary breast carcinoma?
    Taucher S; Rudas M; Mader RM; Gnant M; Dubsky P; Bachleitner T; Roka S; Fitzal F; Kandioler D; Sporn E; Friedl J; Mittlböck M; Jakesz R
    Cancer; 2003 Dec; 98(12):2547-53. PubMed ID: 14669272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
    Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma.
    Choi DH; Shin DB; Lee MH; Lee DW; Dhandapani D; Carter D; King BL; Haffty BG
    Cancer; 2003 Oct; 98(8):1587-95. PubMed ID: 14534873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
    Arafah M
    Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.